22 Recruiting Solid Tumors Phase 2 Clinical Trials
Active phase 2 studies for solid tumors enrolling across the USA. Verify eligibility and contact site coordinators.
All Solid Tumors studiesPhase 2 Studies for Solid Tumors
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
📍 University of California - Los Angeles - 300208353 — Santa Monica, California
View Study & Checklist ➔A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors
📍 The Angeles Clinic and Research Institute — Los Angeles, California
View Study & Checklist ➔Dexamethasone for Symptom Burden in Advanced Cancer Patients
📍 Lyndon Baines Johnson Hospital — Houston, Texas
View Study & Checklist ➔GEN1046 Safety Trial in Patients With Malignant Solid Tumors
📍 Mayo Clinic — Phoenix, Arizona
View Study & Checklist ➔Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
📍 Western Regional Medical Center at Cancer Treatment Centers of America — Goodyear, Arizona
View Study & Checklist ➔Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors
📍 Rigshospitalet — København Ø,
View Study & Checklist ➔Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options
📍 University of California San Diego — La Jolla, California
View Study & Checklist ➔Phase II Biomarker Study of BND-22 in Combination With Cemiplimab in Solid Tumors
📍 Md Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
📍 Henry Ford Health System — Detroit, Michigan
View Study & Checklist ➔DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
📍 USA06-0 — Los Angeles, California
View Study & Checklist ➔APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
📍 Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute — Los Angeles, California
View Study & Checklist ➔A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
📍 New York Medical College — Valhalla, New York
View Study & Checklist ➔JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation
📍 Research Site — Denver, Colorado
View Study & Checklist ➔ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors
📍 UH Cleveland Medical Center — Cleveland, Ohio
View Study & Checklist ➔A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
📍 Local Institution - 0096 — San Francisco, California
View Study & Checklist ➔Optimizing Ancillary Therapies With Immune Checkpoint Inhibitors for Solid Tumors (OAT ICI)
📍 University of Kentucky Markey Cancer Center — Lexington, Kentucky
View Study & Checklist ➔Protecting the Kidney's Proximal Tubules From Platinum-Based Chemotherapy Toxicity
📍 Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán" — México, Tlalpan
View Study & Checklist ➔S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors
📍 Angeles Clinic and Research Center — Los Angeles, California
View Study & Checklist ➔A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
📍 Local Institution - 0005 — Phoenix, Arizona
View Study & Checklist ➔A Study of ZL-1310 in Participants With Selected Solid Tumors
📍 University of California San Francisco/Helen Diller Family Comprehensive Cancer Center — San Francisco, California
View Study & Checklist ➔Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
📍 City of Hope — Duarte, California
View Study & Checklist ➔